ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 59 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $93,000 | -15.5% | 443,731 | -1.1% | 0.00% | – |
| Q2 2022 | $110,000 | -14.1% | 448,731 | 0.0% | 0.00% | – |
| Q1 2022 | $128,000 | -47.3% | 448,731 | +3.2% | 0.00% | – |
| Q4 2021 | $243,000 | -45.1% | 434,621 | 0.0% | 0.00% | – |
| Q3 2021 | $443,000 | -29.2% | 434,621 | -4.1% | 0.00% | – |
| Q2 2021 | $626,000 | -73.0% | 453,321 | -66.8% | 0.00% | – |
| Q1 2021 | $2,319,000 | +45.0% | 1,364,020 | +5.8% | 0.00% | – |
| Q4 2020 | $1,599,000 | +4.2% | 1,289,486 | +19.3% | 0.00% | – |
| Q3 2020 | $1,534,000 | +16.1% | 1,080,509 | -1.1% | 0.00% | – |
| Q2 2020 | $1,321,000 | -21.2% | 1,092,115 | -23.1% | 0.00% | – |
| Q1 2020 | $1,676,000 | -42.7% | 1,420,595 | +2.5% | 0.00% | – |
| Q4 2019 | $2,924,000 | -5.3% | 1,385,805 | -1.3% | 0.00% | – |
| Q3 2019 | $3,088,000 | -4.0% | 1,403,576 | +10.4% | 0.00% | – |
| Q2 2019 | $3,216,000 | +1686.7% | 1,271,167 | +2351.5% | 0.00% | – |
| Q1 2019 | $180,000 | +47.5% | 51,852 | -1.4% | 0.00% | – |
| Q4 2018 | $122,000 | -40.5% | 52,609 | -1.0% | 0.00% | – |
| Q3 2018 | $205,000 | +28.1% | 53,161 | +12.2% | 0.00% | – |
| Q2 2018 | $160,000 | +55.3% | 47,400 | -3.7% | 0.00% | – |
| Q1 2018 | $103,000 | +27.2% | 49,225 | +23.5% | 0.00% | – |
| Q4 2017 | $81,000 | +3.8% | 39,856 | +137.2% | 0.00% | – |
| Q3 2017 | $78,000 | -88.6% | 16,800 | -94.7% | 0.00% | – |
| Q2 2017 | $686,000 | -57.6% | 319,133 | -37.8% | 0.00% | – |
| Q1 2017 | $1,619,000 | +27.7% | 512,877 | +5.1% | 0.00% | – |
| Q4 2016 | $1,268,000 | -31.5% | 487,777 | +2.4% | 0.00% | – |
| Q3 2016 | $1,851,000 | +62.1% | 476,138 | +12.1% | 0.00% | – |
| Q2 2016 | $1,142,000 | +2139.2% | 424,598 | +2427.4% | 0.00% | – |
| Q1 2016 | $51,000 | -21.5% | 16,800 | 0.0% | 0.00% | – |
| Q4 2015 | $65,000 | +32.7% | 16,800 | +3.1% | 0.00% | – |
| Q3 2015 | $49,000 | -56.2% | 16,300 | -38.5% | 0.00% | – |
| Q2 2015 | $112,000 | -92.2% | 26,500 | -92.9% | 0.00% | – |
| Q1 2015 | $1,439,000 | -40.8% | 372,915 | +3.1% | 0.00% | – |
| Q4 2014 | $2,430,000 | +27.0% | 361,872 | +3.7% | 0.00% | – |
| Q3 2014 | $1,913,000 | -45.8% | 348,839 | +1.3% | 0.00% | – |
| Q2 2014 | $3,528,000 | -14.4% | 344,396 | +0.5% | 0.00% | – |
| Q1 2014 | $4,120,000 | +12.7% | 342,835 | +6.2% | 0.00% | – |
| Q4 2013 | $3,655,000 | +18.5% | 322,956 | +12.7% | 0.00% | – |
| Q3 2013 | $3,084,000 | +55.3% | 286,441 | +33.7% | 0.00% | – |
| Q2 2013 | $1,986,000 | – | 214,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |